Stephen joined the Ingham Institute in May 2023 as Chief Executive Officer. Working in close partnership with the South Western Sydney Local Health District (SWSLHD), UNSW and WSU, the Ingham Institute is committed to addressing health issues in South Western Sydney. Research priorities include Neurology & Stroke, Cancer, Obstetrics & Women’s health, Cardiovascular, and Robotics, Medical Devices & Health Technology. Stephen’s focus is primarily around supporting the expansion of the institute to ultimately operate across three sites, creating new research capabilities, enabling research translation and commercialisation, engaging local communities, and working with industry partners.

Stephen has spent more than 15 years within the broader healthcare ecosystem, and joined the Ingham Institute from the Icon Group, where he was CEO of Compounding & Pharmacy Services. Prior to this Stephen had an extensive career with Baxter International, most recently spending 5 years as President and General Manager of Baxter Canada. During his time in Canada, he was a board member of MedTech (the Canadian Medical Device association), the GS1 Healthcare Advisory Council, and the Most Admired Corporate Cultures^TM Board of Governors. More broadly, Stephen’s career spans more than 30 years, with leadership experience across a variety of industries, including roles with Nestlé, Pacific Dunlop, and Procter & Gamble. Stephen holds a First-Class Honours Degree in Chemical Engineering from the University of New South Wales.